Cognition After OSA Treatment Among Native American People (CATNAP)
Cognition After Obstructive Sleep Apnea (OSA) Treatment Among Native American People (CATNAP)
Washington State University
140 participants
Feb 6, 2025
INTERVENTIONAL
Conditions
Summary
This research project will develop and implement a motivational interviewing and electronic messaging intervention to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias in American Indians. The project will work with American Indian Elders, aged 50 years and older, from three Northern Plains Reservations and surrounding communities. A total of 300 American Indian elders with a confirmed OSA diagnosis and prescribed PAP therapy will be randomized to receive usual care consisting of PAP therapy alone (control condition) or usual care plus the culturally informed CATNAP MI component (intervention condition).
Eligibility
Inclusion Criteria6
- Age 50 years and older
- Self report American Indian or Alaskan Native
- diagnosed with obstructive sleep apnea
- prescribed PAP therapy and have a device
- *Ability to understand written and spoken English; and
- *Ability and willingness to follow all study protocols.
Exclusion Criteria3
- Living in a household with someone who is enrolled in the study
- Already using PAP device at Medicaid recommended standards
- Cognitive decline, unable to consent on their own
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Three motivational interviewing (MI) sessions will be facilitated by trained MI staff and will focus on improving participants' knowledge about their OSA diagnosis, understanding of sleep health, and increasing PAP use. Sessions will also provide information about health benefits associated with good sleep and will help participants create an action plan regarding their PAP use and indicators of success, when appropriate. Electronic messaging will be standardized for frequency and content but personalized to participants' preferred mode of delivery. Messages will focus on PAP adherence or non-adherence.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06227572